Okada Rieko, Okada Akira, Okada Takashi, Okada Tohru, Hamajima Nobuyuki
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Med Princ Pract. 2009;18(2):130-6. doi: 10.1159/000189811. Epub 2009 Feb 10.
To study the cause(s) of chronic dyspepsia among patients with no findings on general practice screening tests.
A total of 272 consecutive patients at a general practice in Japan (125 males and 147 females, aged 14-89 years) who underwent abdominal ultrasound (US) and who had serum pancreatic enzyme (lipase or p-amylase) levels measured, were included in a 1-year study. Serum pancreatic enzyme levels were compared according to the duration of the symptoms and causes of dyspepsia, and then compared between two groups: a 'known-cause group' of 38 patients in whom the cause of the chronic (over 1 month) dyspepsia was determined by US or other diagnostic procedures; and an 'unknown-cause group' of 112 patients in whom no cause was found.
The mean lipase level in the unknown-cause group was significantly higher than that in the known-cause group (40.6 vs. 35.3 U/l, p = 0.008 after adjustment for age, sex, and serum creatinine). No difference between these groups was found for p-amylase. The proportion of patients with high lipase levels (above reference range) was higher in the unknown-cause group compared to the known-cause group, although this was not significant (21.4 vs. 10.5%).
Our data showed that serum lipase levels were higher in patients with chronic dyspepsia of unknown than in those with a known cause. We therefore speculate that mild functional pancreatic disorder may underlie some cases with unexplainable chronic dyspepsia.
研究在全科医疗筛查检查未发现异常的患者中慢性消化不良的病因。
在日本一家全科诊所,共有272例连续患者(125例男性和147例女性,年龄14 - 89岁)纳入一项为期1年的研究,这些患者接受了腹部超声(US)检查并检测了血清胰酶(脂肪酶或对淀粉酶)水平。根据症状持续时间和消化不良病因比较血清胰酶水平,然后在两组之间进行比较:38例“已知病因组”患者,其慢性(超过1个月)消化不良的病因通过超声或其他诊断程序确定;以及112例“未知病因组”患者,未发现病因。
未知病因组的平均脂肪酶水平显著高于已知病因组(40.6对35.3 U/l,在对年龄、性别和血清肌酐进行校正后,p = 0.008)。两组之间的对淀粉酶水平无差异。未知病因组中脂肪酶水平高(高于参考范围)的患者比例高于已知病因组,尽管差异不显著(21.4%对10.5%)。
我们的数据表明,慢性消化不良病因不明的患者血清脂肪酶水平高于病因明确的患者。因此,我们推测轻度功能性胰腺疾病可能是某些无法解释的慢性消化不良病例的潜在病因。